Article
Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
Breast cancer research and treatment - 1 Nov 2008
Walker Logan C, Waddell Nic, Ten Haaf Anette, Grimmond Sean, Spurdle Amanda B
Abstract excerpt
Germline mutations in BRCA1 or BRCA2 confer an increased lifetime risk of developing breast or ovarian cancer, but variable penetrance suggests that cancer susceptibility is influenced in part by modifier genes. Microarray expression profiling was conducted for 69 irradiated lymphoblastoid cell l...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
